Three studies affirm efficacy, safety of brolucizumab in DME
WAIKOLOA, Hawaii — Brolucizumab 6 mg demonstrates a favorable benefit-risk profile in the treatment of patients with diabetic macular edema, according to a presentation at Retina 2022.
Promising hypersonic vitrectomy may offer advantages over pneumatic guillotine cutters
WAIKOLOA, Hawaii — Hypersonic vitrectomy is a relatively new method with the potential to innovate vitreoretinal surgery, but surgeons have more to learn about it, according to a presenter at Retina 2022.
VIDEO: PALADIN, NEW DAY studies investigate Iluvien in patients with DME
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Mike Padilla, vice president of marketing at Alimera Sciences, discusses several trials.
Inflammation management important for surgery in patients with uveitis
WAIKOLOA, Hawaii — When performing surgery on patients with uveitis, key points include controlling preoperative inflammation and being willing to question a diagnosis, according to a speaker at Retina 2022.
Lower bevacizumab doses, agents with less systemic exposure may be safer options for ROP
WAIKOLOA, Hawaii — Systemic effects of anti-VEGF in retinopathy of prematurity have not been ruled out, so it may be wise to use bevacizumab in lower doses or switch to agents with less systemic exposure, according to one presenter.
Surgeon gives pearls on successful management of retinal detachment with PVR
WAIKOLOA, Hawaii — Recurrent retinal detachment with proliferative vitreoretinopathy can be effectively managed by vitrectomy, membrane peeling, retinectomy, laser and silicone oil, with the oil then removed 3 to 4 months later.
Monthly aflibercept associated with less progression of retinal nonperfusion
WAIKOLOA, Hawaii — Treatment with monthly aflibercept resulted in less progression of retinal nonperfusion compared with quarterly aflibercept in patients with proliferative diabetic retinopathy, according to a speaker here.
RGX-314 one-time gene therapy for diabetic retinopathy shows promise in phase 2 study
WAIKOLOA, Hawaii — A gene-based therapy, specifically designed to neutralize VEGF activity, may be the next approach to the treatment of diabetic retinopathy, with the advantage of a single suprachoroidal administration.
Expert provides update on latest in retinal imaging
WAIKOLOA, Hawaii — Recent advances in imaging technologies and automated image analysis are bringing about a new era in retinal diagnostics and treatment decision-making.
‘Trickier’ OCTs for pediatric epiretinal membrane still drive better surgical outcomes
WAIKOLOA, Hawaii — While the assessment of pediatric epiretinal membrane in OCT imaging are “trickier” than in adults, they still provide useful data to drive better surgical planning and outcomes, according to a speaker here.